Prosecution Insights
Last updated: May 29, 2026

Mexichem Fluor S A De C V

14 pending office actions • 7 art units • 9 examiners • 0 of 14 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

14
Total Pending OAs
4
Non-Final OAs
10
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

11
Overdue
0
Due this week
1
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (11)Due ≤ 30 days (1)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (29%)
0
Easy (0%)
10
Unknown (71%)

Rejection Statute Mix

BucketCases
§103 only4 (29%)
No statute on record10 (71%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

14
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SAEED, ALI S 4 30.5% +34.8%
HAGHIGHATIAN, MINA 3 45.8% +40.0%
BASQUILL, SEAN M 1 38.6% +22.5%
BAHTA, MEDHANIT W 1 80.5% +28.7%
DOMONE, CHRISTOPHER P 1 84.0% +21.6%
WEINER, LAURA S 1 85.3% +13.6%
DISNEY, CHRISTINE CONLON 1 22.7% +30.1%
IVANOVA, SVETLANA M 1 50.5% +51.9%
GEMBEH, SHIRLEY V 1 63.1% +34.0%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18256253 COMPOSITION DOMONE, CHRISTOPHER P 26d
18044835 COMPOSITION WEINER, LAURA S 56d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17767635 COMPOSITION DISNEY, CHRISTINE CONLON 133d overdue

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17617853 METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT GEMBEH, SHIRLEY V 138d overdue
17767635 COMPOSITION DISNEY, CHRISTINE CONLON 133d overdue
17577824 PHARMACEUTICAL COMPOSITION COMPRISING AN INDACATEROL COMPOUND, A PHARMACEUTICALLY ACCEPTABLE SALT OF GLYCOPYRROLATE AND 1,1-DIFLUOROETHANE IVANOVA, SVETLANA M 35d overdue
16334156 PHARMACEUTICAL COMPOSITION SAEED, ALI S 35d overdue
17460585 PHARMACEUTICAL COMPOSITION COMPRISING TIOTROPIUM BROMIDE MONOHYDRATE SAEED, ALI S 30d overdue
16582710 PHARMACEUTICAL COMPOSITION SAEED, ALI S 30d overdue
16582964 PHARMACEUTICAL COMPOSITION SAEED, ALI S 30d overdue
18259324 PROCESS FOR THE PRODUCTION OF 1,1-DIFLUOROETHANE BAHTA, MEDHANIT W 25d overdue

Top Art Units

Art UnitApps
1616 7
1723 2
1614 1
1692 1
1725 1
1627 1
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18489133 PHARMACEUTICAL COMPOSITION BASQUILL, SEAN M 1614 Other Final Rejection 36d Pending Oct 18, 2023
18259324 PROCESS FOR THE PRODUCTION OF 1,1-DIFLUOROETHANE BAHTA, MEDHANIT W 1692 Other Non-Final OA 25d overdue Pending Jun 26, 2023
18256253 COMPOSITION DOMONE, CHRISTOPHER P 1725 §103 Non-Final OA 26d Pending Jun 07, 2023
18044835 COMPOSITION WEINER, LAURA S 1723 §103 Non-Final OA 56d Pending Mar 10, 2023
17969250 PHARMACEUTICAL COMPOSITION HAGHIGHATIAN, MINA 1616 Other Final Rejection 15d overdue Pending Oct 19, 2022
17944637 PHARMACEUTICAL COMPOSITION HAGHIGHATIAN, MINA 1616 Other Final Rejection 15d overdue Pending Sep 14, 2022
17944666 PHARMACEUTICAL COMPOSITION HAGHIGHATIAN, MINA 1616 Other Final Rejection 15d overdue Pending Sep 14, 2022
17767635 COMPOSITION DISNEY, CHRISTINE CONLON 1723 §103 Final Rejection 133d overdue Pending Apr 08, 2022
17577824 PHARMACEUTICAL COMPOSITION COMPRISING AN INDACATEROL COMPOUND, A PHARMACEUTICALLY ACCEPTABLE SALT OF GLYCOPYRROLATE AND 1,1-DIFLUOROETHANE IVANOVA, SVETLANA M 1627 Non-Final OA 35d overdue Pending Jan 18, 2022
17617853 METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT GEMBEH, SHIRLEY V 1615 §103 Final Rejection 138d overdue Pending Dec 09, 2021
17460585 PHARMACEUTICAL COMPOSITION COMPRISING TIOTROPIUM BROMIDE MONOHYDRATE SAEED, ALI S 1616 Other Final Rejection 30d overdue Pending Aug 30, 2021
16582710 PHARMACEUTICAL COMPOSITION SAEED, ALI S 1616 Other Final Rejection 30d overdue Pending Sep 25, 2019
16582964 PHARMACEUTICAL COMPOSITION SAEED, ALI S 1616 Other Final Rejection 30d overdue Pending Sep 25, 2019
16334156 PHARMACEUTICAL COMPOSITION SAEED, ALI S 1616 Final Rejection 35d overdue Pending Mar 18, 2019

Managing Mexichem Fluor S A De C V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month